Landmark Cancer Clinical Trials and Real-World Patient Populations: Examining Race and Age Reporting
Background: Concern exists that the clinical trial populations differ from respective cancer populations in terms of their age distribution affecting the generalizability of the results, especially in underrepresented minorities. We hypothesized that the clinical trials that do not report race are l...
Enregistré dans:
Auteurs principaux: | Thejus Jayakrishnan, Sonikpreet Aulakh, Mizba Baksh, Kianna Nguyen, Meghna Ailawadhi, Ayesha Samreen, Ricardo Parrondo, Taimur Sher, Vivek Roy, Rami Manochakian, Aneel Paulus, Asher Chanan-Khan, Sikander Ailawadhi |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4902baa6ea224b818c6a583586ed5b2c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Role of Immune Checkpoint Inhibitor Therapy in Advanced EGFR-Mutant Non-Small Cell Lung Cancer
par: Nathaniel Wiest, et autres
Publié: (2021) -
Robotic Pelvic Exenteration for Gynecologic Malignancies, Anatomic Landmarks, and Surgical Steps: A Systematic Review
par: Stefano Cianci, et autres
Publié: (2021) -
Immunotherapy in Non-Small Cell Lung Cancer With Actionable Mutations Other Than EGFR
par: Karan Seegobin, et autres
Publié: (2021) -
The Race of CAR Therapies: CAR-NK Cells for Fighting B-Cell Hematological Cancers
par: Lara Herrera, et autres
Publié: (2021) -
Landmarks: Soering's Legacy
par: Hemme Battjes
Publié: (2008)